Mortality in systemic lupus erythematosus.

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) (2012) 6.51

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum (2011) 3.81

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum (2009) 2.50

Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum (2009) 2.26

Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int (2008) 2.09

Integration of B cell responses through Toll-like receptors and antigen receptors. Nat Rev Immunol (2012) 1.72

A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol (2008) 1.68

The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) (2015) 1.54

Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken) (2011) 1.54

Identification of unique microRNA signature associated with lupus nephritis. PLoS One (2010) 1.53

Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun (2013) 1.47

Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis Rheum (2009) 1.42

Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin North Am (2010) 1.41

Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation. Arthritis Rheumatol (2016) 1.41

Endothelial function is associated with myocardial diastolic function in women with systemic lupus erythematosus. Rheumatol Int (2014) 1.39

Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls. PLoS One (2017) 1.37

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther (2009) 1.29

Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci (2014) 1.26

The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. J Rheumatol (2008) 1.25

Transition of care from paediatric to adult rheumatology. Arch Dis Child (2007) 1.21

Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther (2012) 1.11

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study. Ann Rheum Dis (2016) 1.04

Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Arthritis Res Ther (2010) 1.02

Malignancies in systemic lupus erythematosus. Autoimmun Rev (2009) 1.02

A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheumatol (2014) 1.02

Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population. Clin Exp Med (2010) 1.00

Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 0.99

Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol (2013) 0.98

Global trends, potential mechanisms and early detection of organ damage in SLE. Nat Rev Rheumatol (2012) 0.97

Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus. Ann Rheum Dis (2011) 0.96

Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol (2009) 0.95

Ethnic disparities among patients with systemic lupus erythematosus in South Carolina. J Rheumatol (2008) 0.95

Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care. J Gen Intern Med (2012) 0.93

Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol (2014) 0.93

A new relation between prevalence and incidence of a chronic disease. Math Med Biol (2015) 0.92

Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int (2012) 0.90

Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort. Rheumatology (Oxford) (2009) 0.89

Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011. Arthritis Care Res (Hoboken) (2015) 0.89

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis Rheumatol (2017) 0.89

Burden of systemic lupus erythematosus in Taiwan: a population-based survey. Rheumatol Int (2013) 0.88

Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus. Transl Res (2008) 0.88

Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Pediatr Nephrol (2010) 0.88

Novel therapeutic agents in clinical development for systemic lupus erythematosus. BMC Med (2013) 0.87

Malignancy in systemic lupus erythematosus: what have we learned? Best Pract Res Clin Rheumatol (2009) 0.87

Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox. Arthritis Rheumatol (2015) 0.87

Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort. Lupus (2009) 0.85

Management of cardiovascular complications in systemic lupus erythematosus. Int J Clin Rheumtol (2010) 0.85

[Changes in mortality and morbidity in systemic lupus erythematosus]. Z Rheumatol (2011) 0.85

Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus. Semin Arthritis Rheum (2015) 0.84

Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom. Osteoporos Int (2013) 0.84

Can estrogens promote hypertension during systemic lupus erythematosus? Steroids (2010) 0.83

Atherosclerosis in systemic lupus erythematosus. J Cardiovasc Pharmacol (2013) 0.83

Belimumab in systemic lupus erythematosus: a perspective review. Ther Adv Musculoskelet Dis (2015) 0.83

Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report. BMC Infect Dis (2011) 0.83

Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge. Arthritis Res Ther (2010) 0.83

Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus. Biomed Res Int (2014) 0.82

Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus. Biomed Res Int (2014) 0.82

Systemic lupus erythematosus and vitamin D deficiency are associated with shorter telomere length among African Americans: a case-control study. PLoS One (2013) 0.82

Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry. Arthritis Care Res (Hoboken) (2016) 0.81

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study. Lupus (2013) 0.81

Mesenchymal stem cells for the treatment of systemic lupus erythematosus: is the cure for connective tissue diseases within connective tissue? Stem Cell Res Ther (2011) 0.81

Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy. Lupus Sci Med (2014) 0.81

Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus. Pediatr Nephrol (2012) 0.81

New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol (2016) 0.81

Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) (2015) 0.80

Targeting dendritic cell function during systemic autoimmunity to restore tolerance. Int J Mol Sci (2014) 0.80

Biomarkers and updates on pediatrics lupus nephritis. Rheum Dis Clin North Am (2013) 0.80

Imaging assessment of cardiovascular disease in systemic lupus erythematosus. Clin Dev Immunol (2011) 0.80

Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus. Semin Immunopathol (2014) 0.80

Interobserver agreement on histopathological lesions in class III or IV lupus nephritis. Clin J Am Soc Nephrol (2014) 0.80

Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus. Ann Rheum Dis (2007) 0.79

Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus. Immunology (2015) 0.79

Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus. Arthritis Res Ther (2013) 0.79

Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX). Lupus (2009) 0.78

Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine (Baltimore) (2015) 0.78

Risk of epilepsy in patients with systemic lupus erythematosus - a retrospective cohort study. Neuropsychiatr Dis Treat (2014) 0.78

Death-related factors of systemic lupus erythematosus patients associated with the course of disease in Chinese populations: multicenter and retrospective study of 1,958 inpatients. Rheumatol Int (2012) 0.78

Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis. Springerplus (2014) 0.78

Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review. Clin Rheumatol (2014) 0.78

Why are kids with lupus at an increased risk of cardiovascular disease? Pediatr Nephrol (2015) 0.78

Ultrasound in the interstitial pulmonary fibrosis. Can it facilitate a best routine assessment in rheumatic disorders? Clin Rheumatol (2016) 0.78

Causes and predictors of death in Brazilian lupus patients. Rheumatol Int (2012) 0.78

The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol (2016) 0.77

The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus. Lupus (2009) 0.77

Understanding mechanisms of hypertension in systemic lupus erythematosus. Ther Adv Cardiovasc Dis (2016) 0.77

Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications. Ther Adv Musculoskelet Dis (2015) 0.77

Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE. Nat Rev Rheumatol (2009) 0.77

Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis. BMC Med (2016) 0.77

A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight (2016) 0.77

Pediatric lupus nephritis: Management update. World J Nephrol (2014) 0.77

Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality. Clin Rheumatol (2016) 0.77

Magnetic resonance imaging for characterizing myocardial diseases. Int J Cardiovasc Imaging (2017) 0.76

An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL. Clin Rheumatol (2016) 0.76

Severe systemic lupus erythematosus in emergency department: a retrospective single-center study from China. Clin Rheumatol (2011) 0.76

Lexis diagram and illness-death model: simulating populations in chronic disease epidemiology. PLoS One (2014) 0.76

Successes, Challenges and Lessons Learned: Community-engaged research with South Carolina's Gullah population. Gateways (2013) 0.76

The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis. Semin Nephrol (2015) 0.76

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study. Arthritis Res Ther (2015) 0.76

Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis. BMJ Open (2013) 0.76

Accelerated atherosclerosis in SLE: mechanisms and prevention approaches. Int J Clin Rheumtol (2012) 0.76

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum (1992) 14.73

Ecology. Ecosystem-based fishery management. Science (2004) 10.15

The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum (1991) 7.94

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res (2004) 6.49

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation (2004) 6.43

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum (2001) 5.36

The consultant episode: an unhelpful measure. BMJ (1992) 5.35

A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med (1994) 5.04

Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol (2000) 5.01

Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum (1999) 4.46

NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing Esa1p and the ATM-related cofactor Tra1p. EMBO J (1999) 4.14

The genetic testing of children. Working Party of the Clinical Genetics Society (UK) J Med Genet (1994) 4.12

The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum (1990) 3.97

X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet (1996) 3.90

Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77

Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes. JAMA (1995) 3.73

Quality control of mRNA 3'-end processing is linked to the nuclear exosome. Nature (2001) 3.69

Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol (2001) 3.62

Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature (1990) 3.57

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Ann Rheum Dis (2008) 3.42

Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum (1996) 3.40

Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ (1995) 3.40

The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35

Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 3.35

Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med (1994) 3.32

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32

Efficient purchasing. BMJ (1993) 3.31

Bayesian interim statistical analysis of randomised trials. Lancet (1997) 3.06

Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases. Nat Genet (1996) 3.02

A comparison of the reliability of self-reported drug use and sexual behaviors using computer-assisted versus face-to-face interviewing. AIDS Educ Prev (2000) 3.02

Measuring readmission rates. BMJ (1990) 3.01

Should we test children for "adult" genetic diseases? Lancet (1990) 2.97

The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum (1995) 2.82

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus (2000) 2.81

Birth of a biome: insights into the assembly and maintenance of the Australian arid zone biota. Mol Ecol (2008) 2.73

Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics (2001) 2.72

Psoriatic arthritis precipitated by physical trauma. J Rheumatol (1990) 2.70

Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA (2001) 2.70

Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis (2001) 2.69

Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum (2001) 2.68

Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum (1988) 2.62

Guidelines, enthusiasms, uncertainty, and the limits to purchasing. BMJ (1995) 2.59

Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol (1997) 2.59

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52

The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49

Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients. Ann Rheum Dis (2004) 2.47

A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J (1998) 2.43

A block to mRNA nuclear export in S. cerevisiae leads to hyperadenylation of transcripts that accumulate at the site of transcription. Mol Cell (2001) 2.41

Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2000) 2.40

The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int (2007) 2.40

Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum (1997) 2.40

Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest (1996) 2.39

Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum (1995) 2.38

BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 2.37

Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. Antimicrob Agents Chemother (1972) 2.35

Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis (2004) 2.35

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res (2001) 2.35

The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32

Anti-inflammatory drugs and Alzheimer disease. Lancet (1990) 2.31

Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum (1997) 2.31

West Nile virus surveillance in Connecticut in 2000: an intense epizootic without high risk for severe human disease. Emerg Infect Dis (2001) 2.26

The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26

The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol (1994) 2.23

Effectiveness of a training program in reducing infections in toddlers attending day care centers. Epidemiology (1999) 2.21

Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh. J Occup Environ Med (2000) 2.20

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18